GSK plc (LSE/NYSE: GSK) today announced the launch of the Linked by Lupus: Optimal Care Initiative to help support individuals impacted with lupus, particularly systemic lupus erythematosus (SLE) and ...

Dr. John Watterson, MD, FRCPC, discusses diagnosis and treatment of lupus disease.

Full results from the first phase 3 trial of UCB and Biogen's anti-CD40L antibody dapirolizumab pegol (DZP) in systemic lupus ...

Merck, a leading science and technology company, today announced the presentation of detailed results from Cohort B of the ...

Six of the patients, of whom four had non-renal SLE, had follow-up of at least 24 weeks. Of those, five showed dramatic ...

BARCELONA -- A novel antibody-based drug targeting the CD40 ligand helped close to half of patients with treatment-refractory ...

BOSTON, MA, USA I June 12, 2025 I EMD Serono, the Healthcare business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, a leading science and ...

Cohort B of the Phase 2 study indicates all doses of enpatoran were associated with higher BICLA response rates compared with placebo, though the ...

This unpredictable autoimmune disease presents unique challenges for people with it. This unpredictable autoimmune disease ...

Neonatal lupus consists of a temporary red, raised rash (usually around the eyes and scalp ... Depending on of the type of heart disease your baby has, your doctor may prescribe steroids to you in ...

The malar rash may develop months or years before the onset of lupus. SCLE lesions are described as having ... leaving a small scar. Topical steroids reduce inflammation and can be applied either ...